Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients
LGR5 positively correlated with Ki67, N-cadherin and WHO grade.
»
09/12/18
Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells
Breast carcinoma cells also showed upregulated expression of natural killer group 2 member D.
»
09/12/18
Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial
Supervised WB-EMS training combined with nutritional support shows promising effects against muscle wasting.
»
09/12/18
Endothelial cells promote metastasis of prostate cancer by enhancing autophagy
Elevated autophagy accelerates focal adhesions proteins disassembly.
»
09/10/18
TUSC2P suppresses the tumor function of esophageal squamous cell carcinoma by regulating TUSC2 expression and correlates with disease prognosis
TUSC2P 3’UTR decoyed miR-17-5p, miR-520a-3p, miR-608, miR-661 from binding to TUSC2.
»
09/15/18
Role of Host GPR120 in Mediating Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer.
Higher expression of stromal GPR120 correlated with greater reduction in expression of CCP genes in men with prostate cancer.
»
12/19/17
Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population
Heterogeneity in relationships between parity/breastfeeding, age at first full-term pregnancy, family history, BMI and tumor subtype.
»
09/18/18
miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2)
AgomiR-4317 reduced tumor growth and inhibited FGF9 and CCND2 protein expression.
»
09/18/18
LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer
DLX6-AS1 knockdown inhibited tumor growth and tumor metastasis in vivo.
»
09/18/18
Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes
Grade 3 or higher toxicity rare at 2-years after treatment with PBT.
»
09/17/18
< Prev
Next >